The mammalian homolog of ZYG-8, DCLK1 (doublecortin-like kinase 1), is upregulated in multiple cancers and there are ongoing efforts to generate inhibitors targeting its kinase activity as a therapeutic strategy [28–32]. The gene discussed is DCLK1; the disease is cancer.